biomanufacturing

Aloft Biotechnologies is a pioneering start-up biotechnology company based in Alachua, FL, developing air-film technology for biomanufacturing in space. The company focuses on cell biomanufacturing in microgravity, enabling medicine production at scale, and advancing cell processing in space for medical innovation, biomanufacturing, and deep space life support. Its team brings over 20 years of experience in biomanufacturing, materials engineering, and biomedical science.

aeration and spargingbiomedical sciencebubble and fluid managementcell biomanufacturing in microgravityMaterials engineeringmicrobial culture

Antheia is a next-generation pharmaceutical ingredient manufacturer using a biosynthesis platform to produce biosynthetic Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines. The company engineers complex biosynthesis pathways in yeast and manufactures in contained fermentation environments to create a more efficient, agile, and sustainable alternative to agricultural-based pharmaceutical supply chains.

advanced biosynthesisBioinformaticsdownstream chemistryfermentation process development and scale-upstrain and protein engineeringyeast metabolic engineering

Aspect Biosystems is a Canadian biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how some of the most elusive diseases are treated. Its full-stack tissue therapeutic platform integrates AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials to build allogeneic tissue therapeutics designed to replace, repair, or supplement biological function in the body.

bioprintingcomputational designlab automationmachine learningmicrofluidic printheadsregenerative medicinetissue engineering

Based in Austin, Texas, Attogene is a biotechnology and biomanufacturing company specializing in rapid detection technologies, assay development, environmental monitoring products, molecular biology tools, and custom assay solutions. It develops and manufactures lateral flow assays, ELISA kits, qPCR detection kits, qLAMP assays, enzymatic assays, nucleic acid products, and analytical testing platforms.

custom assay developmentELISA developmentenzymatic assayslateral flow assay developmentnucleic acid testingPCR developmentqLAMP assays

C16 Biosciences is a team of scientists, engineers, brand-builders, and entrepreneurs working to decarbonize consumer products. The company developed a proprietary biomanufacturing platform using fermentation and naturally occurring microorganisms (yeast) to produce high-value lipid ingredients, marketed as Palmless™, for beauty, personal care, home care, and food manufacturers. It reports manufacturing at industrial scale with output capable of producing metric tons of oil per week.

biotechnologyfermentationindustrial-scale oil productionlipid ingredient production

Cresilon is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices using its proprietary hydrogel technology. Its plant-based technology stops traumatic and surgical bleeds in seconds without the need for manual pressure. Product lines target trauma care, biosurgery, and animal health. Founded and headquartered in Brooklyn, NY.

hydrogel technology developmentmanufacturing of hemostatic medical devices

Decycle Bio delivers sustainable chemicals sourced from industrial outputs using its proprietary SynthomeAI platform. The company uses de novo cell-free pathway design combined with advanced enzyme engineering to turn industrial outputs into sustainable chemicals while delivering competitive economics and in-spec performance.

cell-free pathway designdown-stream processingenzyme engineeringenzyme optimizationfeedstock analysispathway designprocess engineering

Early Charm is a vertically integrated company that takes science from research institution licenses to commercial production, with R&D and manufacturing under one roof in Baltimore, Maryland. It serves both defense and commercial markets, developing dual-use products across advanced materials, bioengineering and biodefense, and sensors and analytics. The company reports 90 products in its pipeline and 11 fully commercial products, and is an SBIR/STTR awardee that is DCAA-compliant and SAM + CAGE registered.

3D bioprinting3D printingcastingcoatingcomputational drug designcustom material formulationData Analyticselectrospinningoptical systemspoint-of-care diagnosticsprecision prototypingsonar-based monitoringspectroscopysurface engineering

FluidForm Bio builds living human tissue for better treatment of disease using its patented FRESH 3D bioprinting platform, which builds tissue using cells, proteins, and nothing else. Founded in 2018, the company integrates innovations in 3D printing, computational and synthetic biology, AI and machine learning, and advanced materials science to develop human tissue. Its FRESH 3D bioprinting enables implantable tissue that promotes dense vascularization, with potential application toward a minimally invasive cure for type 1 diabetes.

3D bioprintingadvanced materials scienceAI and Machine Learningcomputational and synthetic biologyFRESH 3D bioprintingtissue engineering

Foray Bioscience pioneers harvest-free plant production, growing plant products without the plant. Using the single cell as nature's building block, the company steers plant cells to create materials, molecules, and seeds, creating a new layer of supply that scales without scaling extraction. It also offers AI-powered software for plant biology (Pando, an intelligent research and development workspace) to accelerate plant innovation across species and applications.

AI-powered plant biology softwarefabricated seed productionplant cell culture

Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world's first approved T cell receptor (TCR) therapy. Built on its proprietary ImmTAX platform, it develops bispecific therapies for cancer, infectious diseases, and autoimmune diseases, including multiple cancers, HIV and HBV.

bispecific therapy developmentclinical developmentCMC developmentT cell receptor (TCR) therapy discovery and development

JAMMX provides NEPA, TSCA, RCRA, CWA, CAA compliant environmental consulting, plasma-based waste remediation, biotechnology, IT, and software engineering solutions to government and commercial customers. The company is registered and compliant for federal contracting opportunities.

environmental consultingIT serviceslaboratory operationsplasma-based waste remediationquality systemsRegulatory ComplianceScale upsoftware engineering

June Bio is a Copenhagen-based biotech company innovating in glycobiology, biomanufacturing, and immunology to restore mucosal health. Its journey began with discoveries in glycobiology and mucin biology at Cornell University, and it is supported by the BioInnovation Institute. June Bio was launched in 2025 by Frederik Madsen, Thomas Crouzier, and Matt DeLisa, and is developing scalable, affordable production of mucins to rebuild the body's natural mucosal defense.

glycobiologyglycoengineeringimmunologymicrobial biomanufacturingscalable mucin production

Kemp Proteins specializes in providing innovative solutions to protein expression problems, offering gene-to-protein bioservices for the life science and research industry. With more than 20 years of experience, its team of protein scientists has completed more than 20,000 projects, delivering timely, high-quality gene-to-protein services to help clients optimize productivity and mitigate risk in discovery, development, and manufacturing programs.

analytical characterizationantibody developmentBacMam expressionbaculovirus expressioncell bankingE. coli expressionhigh throughput expression and purificationhybridoma-to-recombinant conversionlyophilizationmammalian transient and stable transfectionOEM vialingprotein expressionpurificationSPR/BLI affinity characterizationstable cell line developmentyeast expression